REACT – REAl Care for AsThma - A disease study to identify patients with severe uncontrolled asthma

Trial Identifier: D3250R00116
Sponsor: AstraZeneca
NCTID:: NCT06299306
Start Date: May 2024
Primary Completion Date: January 2026
Study Completion Date: January 2026
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Germany Berlin, Germany
Germany Blankenhein, Germany
Germany Bonn, Germany
Germany Fuerstenwalde, Germany
Germany Gauting, Germany
Germany Weissenburg, Germany